A N ATA R A L I F E S C I E N C E S LT D Annual Report 2026 A B N 4 1 1 4 5 2 3 9 8 7 2 1 A N ATA R A L I F E S C I E N C E S LT D A N D C O N T R O L L E D E N T I T Y A B N : 4 1 1 4 5 2 3 9 8 7 2 Consolidated Financial Statements F O R T H E Y E A R E N D E D 3 0 J U N E 2 0 2 6 A N ATA R A L I...
Annual Report to shareholders
Filed with ASX ·
6ix hasn’t read this filing yet.
Anatara Lifesciences Ltd on 6ix
Earlier from Anatara Lifesciences
- Quarterly Activities/Appendix 4C Cash Flow Report
- Date of 2026 Annual General Meeting
- Anatara receives $318,402 in R&D Tax Incentive for FY26
- Change of Director's Interest Notice
- Application for quotation of securities - ANR
Later from Anatara Lifesciences
- Appendix 4G & Corporate Governance Statement
- Notice of Annual General Meeting/Proxy Form
- Change of Registry Address Notification
